CD163 and gastric cancer: The CD163+ and CD11b+ tumor-associated macrophages (TAMs) have been associated with a poor prognosis for gastric cancer patients, and the increased number of M1 macrophages may be associated with a better OS for gastric cancer patients 42,43.